Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
China · Delayed Price · Currency is CNY 10.72
+0.05 (0.47%)
Sep 8, 2026, 11:29 AM CST
Shanghai No.1 Pharmacy Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,380 | 2,885 | 3,012 | 2,681 | 2,516 | 2,086 | |
Market Cap Growth | -25.85% | -4.22% | 12.31% | 6.56% | 20.64% | -3.91% |
Enterprise Value | 2,115 | 2,596 | 2,866 | 2,346 | 2,569 | 1,904 |
Last Close Price | 10.67 | 12.82 | 13.16 | 11.59 | 10.73 | 8.83 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.92 | 49.95 | 18.47 | 30.04 | 17.53 | 42.21 |
PS Ratio | 1.13 | 1.35 | 1.57 | 1.47 | 0.95 | 1.49 |
PB Ratio | 2.11 | 2.46 | 2.63 | 2.66 | 2.63 | 2.68 |
P/TBV Ratio | 2.19 | 2.56 | 2.75 | 2.79 | 2.77 | 2.88 |
P/FCF Ratio | 57.78 | 39.54 | - | 60.10 | 20.81 | 87.20 |
P/OCF Ratio | 43.50 | 32.45 | 61.43 | 45.84 | 19.02 | 57.05 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.00 | 1.22 | 1.50 | 1.29 | 0.97 | 1.36 |
EV/EBITDA Ratio | 39.09 | 2003.46 | 147.48 | 124.87 | 11.99 | 113.95 |
EV/EBIT Ratio | - | - | 240.29 | 205.57 | 12.43 | 213.09 |
EV/FCF Ratio | 51.33 | 35.59 | - | 52.59 | 21.24 | 79.61 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.19 | 0.24 | 0.26 | 0.48 | 0.13 |
Debt / EBITDA Ratio | 1.53 | 3.52 | 3.54 | 4.08 | 1.80 | 1.88 |
Debt / FCF Ratio | 2.01 | 3.03 | - | 5.98 | 3.78 | 4.26 |
Net Debt / Equity Ratio | -0.24 | -0.17 | -0.23 | -0.23 | -0.32 | -0.21 |
Net Debt / EBITDA Ratio | 51.21 | -154.69 | -13.50 | -12.23 | -1.43 | -9.59 |
Net Debt / FCF Ratio | -6.69 | -2.75 | 90.12 | -5.15 | -2.54 | -6.70 |
Asset Turnover | 1.08 | 1.07 | 1.00 | 0.93 | 1.58 | 1.02 |
Inventory Turnover | 4.55 | 5.18 | 4.78 | 4.42 | 7.70 | 5.36 |
Quick Ratio | 0.98 | 0.99 | 1.17 | 1.13 | 1.11 | 0.96 |
Current Ratio | 1.67 | 1.59 | 1.74 | 1.65 | 1.51 | 1.49 |
Return on Equity (ROE) | 6.30% | 5.06% | 15.20% | 9.08% | 16.53% | 6.47% |
Return on Assets (ROA) | -0.40% | -0.19% | 0.39% | 0.37% | 7.66% | 0.41% |
Return on Invested Capital (ROIC) | -1.05% | -0.50% | 1.09% | 1.21% | 24.54% | 1.31% |
Return on Capital Employed (ROCE) | -1.00% | -0.40% | 0.90% | 1.00% | 18.60% | 1.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.94% | 2.00% | 5.41% | 3.33% | 5.71% | 2.37% |
FCF Yield | 1.73% | 2.53% | -0.10% | 1.66% | 4.81% | 1.15% |
Dividend Yield | 0.73% | 0.61% | 1.67% | 1.08% | 1.82% | 0.79% |
Payout Ratio | 95.61% | 87.96% | 18.04% | 53.97% | 19.09% | 45.41% |
Buyback Yield / Dilution | 0.51% | 0.57% | -0.08% | 0.50% | 0.14% | -1.60% |
Total Shareholder Return | 1.24% | 1.18% | 1.59% | 1.58% | 1.96% | -0.80% |